3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Status
Active not recruiting
3
Sponsor Class
INDUSTRY
3
Study Type
Interventional
3
Sponsor
Cancer Type
Thoracic
3
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
3
Colorectal Neoplasms
3
Neoplasm Metastasis
1
Interventions
Specimen Handling
51
Carboplatin
49
pembrolizumab
45
Magnetic Resonance Spectroscopy
43
Pemetrexed
39
Cisplatin
34
Paclitaxel
24
durvalumab
23
osimertinib
20
Nivolumab
19
Gemcitabine
19
Radiosurgery
17
Docetaxel
17
atezolizumab
14
Taxes
12
Radiotherapy
12
Immunoglobulin G
12
Disulfides
12
130-nm albumin-bound paclitaxel
12
Etoposide
11
Educational Status
11
Biopsy
11
Radiation
10
Drug Therapy
10
Blood Specimen Collection
10
Platinum
9
Early Intervention, Educational
9
Cetuximab
9
Methods
8
Bevacizumab
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
JDQ443
×
90 days
×
Clear all
NCT05132075
2026-06-02
KontRASt-02
Novartis
Phase 3
Active not recruiting
95 enrolled
NCT05445843
2026-05-14
KontRASt-06
Novartis
Phase 2
Active not recruiting
95 enrolled
20 charts
NCT04699188
2026-03-18
KontRASt-01
Novartis
Phase 1/2
Active not recruiting
344 enrolled